David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
CALL
Neumora Therapeutics
NMRA
$286M
| $133K | ﹤0.01% |
+12,500
| New | +$150K |
|
4002
CALL
Hecla Mining
HL
$13.7B
| $131K | ﹤0.01% |
+26,600
| New | +$159K |
|
4003
Nuvation Bio
NUVB
$2.37B
| $126K | ﹤0.01% |
47,400
-63,827
| -57% | -$164K |
|
4004
CALL
Blink Charging
BLNK
$84.7M
| $125K | ﹤0.01% |
90,000
| – | – |
|
4005
LG Display
LPL
$3.29B
| $122K | ﹤0.01% |
+39,902
| New | +$141K |
|
4006
Lifezone Metals Ltd Warrants
LZM.WS
$34.8M
| $122K | ﹤0.01% |
166,366
| – | – |
|
4007
Kosmos Energy
KOS
$1.7B
| $122K | ﹤0.01% |
35,700
+20,700
| +138% | +$78.8K |
|
|
AVDL
4008
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
| $122K | ﹤0.01% |
+11,600
| New | +$141K |
|
4009
Barings BDC
BBDC
$989M
| $122K | ﹤0.01% |
+12,737
| New | +$125K |
|
|
HCVIW
4010
DELISTED
Hennessy Capital Investment Corp. VI Warrant
HCVIW
| $120K | ﹤0.01% |
990,000
| – | – |
|
4011
PUT
Ecopetrol
EC
$35.6B
| $120K | ﹤0.01% |
+15,100
| New | +$122K |
|
4012
EverCommerce
EVCM
$1.69B
| $119K | ﹤0.01% |
+10,782
| New | +$120K |
|
4013
CALL
Goodyear
GT
$1.73B
| $117K | ﹤0.01% |
13,000
| – | – |
|
4014
Allogene Therapeutics
ALLO
$701M
| $116K | ﹤0.01% |
54,517
-35,808
| -40% | -$88.3K |
|
4015
Veritone
VERI
$86M
| $116K | ﹤0.01% |
35,244
-151,780
| -81% | -$492K |
|
|
VTYX
4016
DELISTED
Ventyx Biosciences
VTYX
| $114K | ﹤0.01% |
52,231
-54,437
| -51% | -$123K |
|
|
THRD
4017
DELISTED
Third Harmonic Bio
THRD
| $113K | ﹤0.01% |
11,000
-2,967
| -21% | -$37K |
|
4018
Tilly's
TLYS
$114M
| $113K | ﹤0.01% |
26,510
| – | – |
|
4019
Arteris
AIP
$1.11B
| $110K | ﹤0.01% |
+10,773
| New | +$89K |
|
4020
Radiant Logistics
RLGT
$395M
| $109K | ﹤0.01% |
16,328
-5,557
| -25% | -$38.3K |
|
4021
Stagwell
STGW
$2.17B
| $109K | ﹤0.01% |
+16,578
| New | +$118K |
|
4022
Marqeta
MQ
$1.7B
| $106K | ﹤0.01% |
6,987
-89,126
| -93% | -$1.56M |
|
|
SBDS
4023
DELISTED
Solo Brands Inc
SBDS
| $104K | ﹤0.01% |
2,284
+5
| +0.2% | +$248 |
|
|
ARI
4024
Apollo Commercial Real Estate
ARI
$883M
| $103K | ﹤0.01% |
11,841
-17,753
| -60% | -$160K |
|
|
ATXS
4025
DELISTED
Astria Therapeutics
ATXS
| $102K | ﹤0.01% |
11,375
+1,207
| +12% | +$12.8K |
|
Similar funds
David Shaw's Q4 2024 Portfolio in Review
As of Q4 2024, David Shaw held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- David Shaw's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- David Shaw's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- David Shaw fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- David Shaw's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- David Shaw opened 591 new positions and closed 731 in Q4 2024.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.